Recruiting NA INTERVENTIONAL 2-arm NCT04861415

SBRT vs. Conventional Fractionation With HDR Boost for Prostate Cancer (SHARP)

A Randomized Feasibility Trial of Stereotactic Body Radiotherapy Versus Conventional Fractionation With High Dose-rate (HDR) Brachytherapy Boost for Prostate Cancer

Sponsor: Dr. Gerard Morton

Conditions Prostate Cancer

Interventions Conventionally Fractionated Radiation Sterotactic Body Radiotherapy

Updated 5 times since 2021 Last updated: Apr 11, 2023 Started: Dec 23, 2020 Primary completion: Jun 23, 2023 Completion: Dec 23, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04861415, this NA trial focuses on Prostate Cancer and remains actively recruiting participants. Sponsored by Dr. Gerard Morton, it has been updated 5 times since 2020, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
May 2023 — Jul 2024 [monthly]

Recruiting NA
Jun 2022 — May 2023 [monthly]

Recruiting NA
May 2021 — Jun 2022 [monthly]

Recruiting NA

First recorded

Dec 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dr. Gerard Morton

Data source: Sunnybrook Health Sciences Centre

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toronto, Canada